Skip to Content

We measure success in health outcomes.

Technology adoption is not the end goal.

We measure whether patients are being identified, connected to care, treated appropriately, retained in care, and ultimately achieving better health outcomes.

Impact through FY26

People screened

2.2M

Patients enrolled

457K

Lives improved

243K

Health workers trained

10K

Evidence across the care pathway.

Screening yield

~4x

Risk-based screening compared with blanket screening.

Systolic blood pressure

-8.2 mmHg

Greater reduction among patients enrolled through screening compared with previously known patients.

Systolic blood pressure

-6.9 mmHg

Greater reduction among patients treated at primary care compared with district hospitals.

Severe hypertension

60% fewer

Patients with severe hypertension within six months.

Real-world evidence at scale.

140,000+

patients enrolled

246

facilities

4

countries

63,003

patients in the outcome analysis

Blood pressure control improved by 18 percentage points.

One of our largest studies evaluated digital hypertension care across four sub-Saharan African countries. Among patients included in the outcome analysis, blood pressure control increased from 35% to 53%.

Read the peer-reviewed study

Reports

impact report

FY23

impact report

FY22

impact report

FY21

impact report

FY20

Medtronic LABS Africa Overview

Medtronic LABS Asia Overview

Back to top